Aidoc Medical Ltd.

Founded in 2016 and based in New York, US, Aidoc Medical Ltd. operates as a provider of an AI-based software solution that helps radiologists in analyzing medical scans and images, as well as patients' data. The firm was co-founded by Elad Walach, and Michael Braginsky. In July 2025, Aidoc Medical Ltd.

raised USD 150 million in venture funding co-led by returning investors General Catalyst Partners and Square Peg, with participation from new investors NVentures, Hartford HealthCare Corporation, Mercy, Sutter Health, and WellSpan Health. Other unspecified investors also participated in the round. The company’s offerings include AI and deep learning-based detection and triage software, that analyses medical images, and alerts the abnormalities across the body, enabling radiologists to reduce turnaround time and enhance the quality of medical care, PE (Pulmonary Embolism) care coordination software, an AI-powered product suite that allows for quick triage of investigations in suspected PE patients as well as care coordination for intermediate to high-risk patients, and Stroke care coordination suite etc. The company generated revenue from health systems deploying Aidoc’s aiOS and CARE-powered solutions.

This positions Aidoc to expand its CARE foundation model and scale clinical decision support across 100 million patients. The company will use the July 2025 funding for the expansion of aiOS and further development of CARE.